Summary
Other Scenarios:
- ARRO - JNJ
- JNJ - BLUD
| Buyer: | Arrow International, Inc. (ARRO) | Last Price: | 32.09 | Market Cap.: | 1.44B |
|---|---|---|---|---|---|
| Target: | Immucor, Inc. (BLUD) | Last Price: | 21.19 | Market Cap.: | 1.43B |
Lines of Business Summary:
- Arrow International, Inc. (ARRO) competes in 1 industry and 51 product/service groups
- Immucor, Inc. (BLUD) competes in 1 industry and 21 product/service groups
- A combined entity will have 0% Product/Service Group overlap
Product Summary:
Overlap & Complementary Sectors
| Sector | Buyer | Target | # of Focused Companies |
|---|---|---|---|
*Healthcare |
|
|
864 |
Biopharmaceuticals |
|
321 | |
Medical Devices |
|
|
243 |
Scientific Products |
|
42 |
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Sample Products in Similar Lines of Business |
Sample Products in Complementary Lines of Business |
||
Buyer (Total: 86)
|
Target (Total: 59)
|
Buyer
|
Target
|
Business Relationship Summary:
Top Key Suppliers |
Top Key Customers |
||
Buyer (Total: 1)
|
Target (Total: 4)
|
Buyer (Total: 0)n/a |
Target (Total: 3)
|
Key Financial Summary:
Key Metrics
| Buyer | Target | |
|---|---|---|
| Number of Employees | 3,700 | 563 |
| Revenue Per Employee | 132,532.8 | 357,816.0 |
| Total Revenue | 122.3 | 50.0 |
| Total Expenses | 103.0 | 31.2 |
Other Revenue
|
0.0 | 0.0 |
Cost of Revenue
|
63.0 | 15.8 |
SG&A Expense
|
32.6 | 14.0 |
Research & Development
|
7.2 | 1.2 |
Other Operating Expense
|
0.0 | 0.0 |
Operating Income
|
19.3 | 18.7 |
Unusual Income
|
0.1 | 0.1 |
LT Debt to Capital
|
0 | 0 |
Fwd P/E
|
26.06 | 28.47 |
Fwd P/Rev
|
3.03 | 6.69 |
| Book Value | 506.1 | 143.9 |
Curr Portion of LTD/Cap Lease
|
1.0 | 1.1 |
Key Ratios
| Buyer | Target | |
|---|---|---|
Gross Margin %
|
46.76 | 66.23 |
Operating Margin %
|
12.5 | 34.35 |
Quick Ratio
|
1.99 | 3.33 |
Current Ratio
|
3.1 | 4.33 |
Coverage Ratio
|
0.05 | 0.01 |
| Total Assets | 643.9 | 191.7 |
| Return on Equity % | 8.58 | 27.69 |
| Return on Assets % | 6.74 | 20.78 |
Cash+ ST Inv. Per Share
|
2.94 | 0.79 |
| Total Debt | 53.2 | 1.1 |
| Total Debt to Equity % | 10.51 | 0.75 |
| Total Debt to Tangible Equity % | 12.82 | 1.02 |
Debt to Asset %
|
8.26 | 0.56 |
Individual Company Summary
Focused
Buyer
Focused (
):
*Healthcare > Medical Devices > Drug Delivery > Infusion Therapy > Vascular Access
Target
Focused (
):
*Healthcare > Medical Devices > Transfusion Medicine > Immunohematology
Business Description
Buyer
Arrow International, Inc. develops, manufactures and markets a range of clinically advanced, disposable catheters and related products for critical and cardiac care. The Company's critical care products are used principally for central vascular access in the administration of fluids, drugs and blood products, patient monitoring and diagnostic purposes. These products are used by anesthesiologists, critical care specialists, surgeons, cardiologists, nephrologists, emergency and trauma physicians, and other healthcare providers. Arrow's cardiac care products are used by interventional cardiologists, cardiac surgeons, interventional radiologists and electrophysiologists for purposes, such as the diagnosis and treatment of heart and vascular disease, and to provide short-term cardiac assist following cardiac surgery, serious heart attack or balloon angioplasty.
Target
Immucor, Inc. (Immucor) develops, manufactures and sells a complete line of reagents and automated systems used primarily by hospitals, clinical laboratories and blood banks in a number of tests performed to detect and identify certain properties of the cell and serum components of human blood prior to blood transfusion. On July 5, 2005, the Company acquired Immucor-Kainos, Inc., a newly formed company. The Company operates facilities in North America, Europe and Japan.
Product Summary
| Sector | Buyer | Target |
|---|---|---|
*Healthcare |
|
|
Biopharmaceuticals |
|
|
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
|
|
|
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
|
|
|
Medical Devices |
|
|
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
|
|
|
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
|
|
|
Clinical Diagnostics
The Clinical Diagnostics Subsector includes medical devices that analyze human body specimens within a medical setting. These devices, including equipment, biological and chemical reagents are primarily used for the diagnosis of diseases.
|
|
|
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
|
|
|
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
|
|
|
Neonatology
The Neonatology Subsector includes medical devices that diagnose, monitor and treat diseases of newborns.
|
|
|
Oncology
The Oncology Subsector includes medical devices that detect and treat cancers.
|
|
|
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
|
|
|
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
|
|
|
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
|
|
|
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
|
|
|
Scientific Products |
|
|
Bioanalytical Instruments
The Bioanalytical Instruments Subsector includes scientific products, devices and apparatuses that determine the quantitative and qualitative nature of a biological samples.
|
|
|
General Laboratory Equipment
The General Laboratory Equipment Subsector includes products that are used during routine laboratory procedures, such as sample preparation, processing, storage, cleaning, and purification.
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Product Details
| Sector | Buyer | Target |
|---|---|---|
*Healthcare |
|
|
Biopharmaceuticals |
|
|
Infectious Diseases |
|
|
Bacterial |
|
|
Antibacterial Agents |
|
|
Broad Spectrum |
|
|
Antiseptic Agents
Therapeutics that prevent bacterial infection by inhibiting the growth and development of microorganisms without necessarily killing them.
Buyer Products:
|
|
|
Surgery |
|
|
General |
|
|
Bacterial Infections |
|
|
Antiseptic Agents
Therapeutics that are used to prevent the spread of microorganism in pre-surgical skin infections due to bacteria.
Buyer Products:
|
|
|
Medical Devices |
|
|
Anesthesiology |
|
|
Surgical |
|
|
Procedure/Region Specific |
|
|
Delivery Systems |
|
|
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syrninges and other prepackaged kits.
Buyer Products:
|
|
|
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.
Buyer Products:
|
|
|
Cardiology |
|
|
Diagnostic |
|
|
Imaging |
|
|
X-Ray |
|
|
Angiography |
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Buyer Products:
|
|
|
Monitoring |
|
|
Accessories |
|
|
Blood Pressure |
|
|
Invasive Blood Pressure Cuffs
Monitoring accessories that require contact with the blood and blood vessels to obtain an accurate blood pressure reading, such as domes and transducers.
Buyer Products:
|
|
|
Output Sensors
Instruments that measure various cardiac outputs, such as blood velocity and pressure. Examples of sensors include bioimpedence, hemodynamic and thermodilution catheters.
Buyer Products:
|
|
|
Monitors |
|
|
Cardiac Output
Instrument that measures the blood flow pumped out of the heart.
Buyer Products:
|
|
|
Surgical |
|
|
General Procedure |
|
|
Accessories |
|
|
Access |
|
|
Arterial
Instruments used to gain access to the heart's arteries, including aortic pouches, introducer needles, introducers and vessel dilators.
Buyer Products:
|
|
|
Guidewires
A small wire-like device that is threaded through a catheter to the site of interest for delivery of another apparatus like a stent.
Buyer Products:
|
|
|
Procedure/Region Specific |
|
|
Arrhythmia |
|
|
Electrophysiology |
|
|
Chamber Mapping Systems |
|
|
Catheters
Long slender wire-like devices with multiple electrodes on the end that gets inserted into the heart chamber for electrophysiological studies and chamber mapping.
Buyer Products:
|
|
|
Guiding Catheters
Catheter that is used to guide other instruments into place, usually has some sort of curve or steering mechanism.
Buyer Products:
|
|
|
Pacing Catheters
Catheter that is capable of regulating the electrical stimulation rhythm of the heart.
Buyer Products:
|
|
|
Cardiac Output Assist |
|
|
Intra-Aortic Balloon Pump (IABP) |
|
|
Accessories
Various instruments used to assist intra aortic balloon pump surgery, such as catheter kits and introducers.
Buyer Products:
|
|
|
Systems
Complete set of instruments used to perform intra aortic balloon pump surgery.
Buyer Products:
|
|
|
Ventricular Assist Device (VAD) |
|
|
Left Ventricular (LVAS) |
|
|
Implantable
A device that can be encased in the body cavity and provides the pumping force for the left ventricle of the heart.
Buyer Products:
|
|
|
Revascularization |
|
|
Atherectomy |
|
|
Rotational Systems
Complete set of instruments used to perform catheter based rotational blade atherectomy.
Buyer Products:
|
|
|
Clinical Diagnostics |
|
|
Immunoassays |
|
|
Reagents |
|
|
Test Kits |
|
|
Special/Immuno Chemistry |
|
|
Fertility/Reproduction |
|
|
B-hCG
Immunoassay test kits which quantitatively measures beta hCG, human chorionic gonadotrophin, in plasma or serum.
Target Products:
|
|
|
Specimen Collection |
|
|
Blood |
|
|
Arterial |
|
|
ABG Collection Kits
Collection devices used to collect arterial blood samples.
Buyer Products:
|
|
|
Body Fluids |
|
|
Paracentesis Kits
Kits used in the collection of paracentesis fluid.
Buyer Products:
|
|
|
Thoracentesis Kits
Catheters/thin tubes used to collect samples of fluid in the thoracic fluid for diagnostic and therapeutic purposes
Buyer Products:
|
|
|
Drug Delivery |
|
|
Infusion Therapy |
|
|
Accessories |
|
|
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.
Buyer Products:
|
|
|
Delivery Systems |
|
|
Pumps |
|
|
Subcutaneous
Pump placed under the skin of the patient receiving infusion therapy.
Buyer Products:
|
|
|
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.
Buyer Products:
|
|
|
Vascular Access |
|
|
Extended In Dwelling Catheters |
|
|
Central Venous Catheters (CVC)
Catheters designed to handle high volume flow.
Buyer Products:
|
|
|
Introducers
Medical devices designed for introducing vascular access.
Buyer Products:
|
|
|
Kits
Kits containing necessary components for gaining vascular access, such as midline catheters, peripherally inserted central catheters, central venous catheters, and associated repair instruments.
Buyer Products:
|
|
|
Midline Catheters
Central venous catheter set designed for midline venous access.
Buyer Products:
|
|
|
Peripherally Inserted Central Catheters (PICC)
Central venous catheter set designed for peripheral venous access.
Buyer Products:
|
|
|
Peripheral Intravenous Catheters |
|
|
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.
Buyer Products:
|
|
|
Ported
Peripheral intravenous catheters that have ports for access and to attach other devices such as infusion pumps.
Buyer Products:
|
|
|
Safety Catheters
Catheters designed to protect healthcare workers from accidental needle punctures.
Buyer Products:
|
|
|
Subcutaneous Implants |
|
|
Accessories |
|
|
Port Access
Devices that permit port introduction allowing controlled vascular access.
Buyer Products:
|
|
|
Ports
Implanted devices that allow controlled vascular access.
Buyer Products:
|
|
|
General Surgery |
|
|
Invasive |
|
|
Accessories |
|
|
Drainage
Medical instruments used to provide drainage in the surgical area, including access kits, catheters, evacuator kits and reservoirs.
Buyer Products:
|
|
|
Guidewires
Guidewires used to lead other medical devices into place during surgical procedures
Buyer Products:
|
|
|
Instruments |
|
|
Manual Instruments
Medical devices used manually by surgeons to perform invasive general surgical procedures, such as scalpels, curettes, dissectors, elevators, forceps, osteotomes, retractors, bissectors and other similar items.
Buyer Products:
|
|
|
Procedure/Region Specific |
|
|
Cholecystectomy |
|
|
Cholangiography |
|
|
Needles
Needles used to assist in cholangiography.
Buyer Products:
|
|
|
Minimally Invasive |
|
|
Procedure/Region Specific |
|
|
Cholecystectomy |
|
|
Cholangiography
Devices used to perform minimally invasive procedures involving the biliary system, including catheter kits and other endoscopic instruments.
Buyer Products:
|
|
|
Neonatology |
|
|
Surgical |
|
|
Accessories |
|
|
Drainage Catheters
Long slender wire-like tube device that gains access to internal compartments of a newborn and allows fluid to exit through it.
Buyer Products:
|
|
|
Treatment |
|
|
Feeding Tubes
A pipe-like instrument that allows food to enter the newborn's stomach.
Buyer Products:
|
|
|
Urinary Drainage |
|
|
Systems
Complete set of instruments to remove the urine in a newborn's bladder.
Buyer Products:
|
|
|
Vascular Access |
|
|
Umbilical Vessel Catheters
Long slender wire-like tube device that proceeds down the umbilical cord to provide access to the inside of the newborn.
Buyer Products:
|
|
|
Oncology |
|
|
Surgical |
|
|
Biopsy |
|
|
Region Specific |
|
|
Liver
Instruments used to obtain biopsy sample from the liver system.
Buyer Products:
|
|
|
Respiratory |
|
|
Treatment |
|
|
Pneumothorax Catheter Kits
Thin tubes designed to be inserted into the lungs to correct pneumothorax (collapsed lung).
Buyer Products:
|
|
|
Transfusion Medicine |
|
|
Blood Washers
Instruments used to wash blood cells in preparation for usage; they are often used to prepare frozen red blood cells for transfusion.
Target Products:
|
|
|
Immunohematology |
|
|
Automated Blood Typing
Analyzers used to automate the blood typing process.
Target Products:
|
|
|
Non-Automated Typing |
|
|
Reagents |
|
|
Adsorption Cells
Cells used to adsorb specific antibodies which may be interfering with a immunological reaction being tested for.
Target Products:
|
|
|
Anti-Human Globulin
Solution containing antibodies against multiple human blood cell antigens used in clinical blood banks.
Target Products:
|
|
|
Antibody Enhancement Media
Media solutions used to enhance antigen/antibody reactions in blood banking procedures.
Target Products:
|
|
|
Antibody Screening |
|
|
Infectious Disease
Test kits used in blood banks to test for infectious diseases.
Target Products:
|
|
|
Platelet
Reagents used to test for antibodies against platelets in donor blood.
Target Products:
|
|
|
Red Cell
Reagents used to test for antibodies against red blood cells in donor blood.
Target Products:
|
|
|
Blood Group Substances
Specific substances secreted by individuals with specific blood types which can be tested for.
Target Products:
|
|
|
Controls
Devices used to verify performance of reagents and systems in the clinical blood bank.
Target Products:
|
|
|
Elution Cells
Cells used to remove un-desirable antibodies by elution prior to specific antibody testing.
Target Products:
|
|
|
Fetal Screen
Kits used to test for fetal blood cells in the maternal blood circulation as a measure of fetal sensitization to the mothers blood during childbirth.
Target Products:
|
|
|
Monoclonal Antibody |
|
|
ABO Blood Group
Antibodies used for typing blood into the major antigenic blood groups.
Target Products:
|
|
|
Rh Blood Group
Antibodies used for determining the D antigen on red blood cells.
Target Products:
|
|
|
Special Blood Grouping
Antibodies used for special blood typing
Target Products:
|
|
|
Polyclonal Antibodies
Antibodies derived from a multiple cell lines use for immunohematology studies.
Target Products:
|
|
|
Product Labeling |
|
|
Software
Software designed for donor blood labeling systems.
Target Products:
|
|
|
Urology |
|
|
Surgical |
|
|
Procedure/Region Specific |
|
|
Percutaneous |
|
|
Nephrostomy |
|
|
Drainage Instruments
Instruments used to remove waste fluid from the kidney, such as catheters, malecots, pezzers, nephrostomy tubes and other similar items.
Buyer Products:
|
|
|
Treatment |
|
|
Renal |
|
|
Hemodialysis |
|
|
Components |
|
|
Access Graft Thrombolysis
Device used to plug up the hole in the access vein used for hemodialysis.
Buyer Products:
|
|
|
Catheters |
|
|
Central Venous Access (CVA)
Catheter that gains access to a major vein.
Buyer Products:
|
|
|
Sets
Complete set of catheter instruments used to gain access to internal blood vessels for hemodialysis.
Buyer Products:
|
|
|
Vascular |
|
|
Diagnostic |
|
|
Imaging |
|
|
X-Ray |
|
|
Angiography |
|
|
Accessories
Various instruments used to assist in angiography procedures, including transducers, catheters, control syringes, waste systems, contrast management systems, fluid administration sets, and other related items.
Buyer Products:
|
|
|
Surgical |
|
|
General Procedure |
|
|
Accessories |
|
|
Introducer Needles
Devices which provide access to the vascular system for introduction of introducers.
Buyer Products:
|
|
|
Introducers
Devices used to provide percutaneous introduction of catheters, interventional devices, and temporary pacing leads into the vasculature.
Buyer Products:
|
|
|
Scientific Products |
|
|
Bioanalytical Instruments |
|
|
Biomolecular |
|
|
Microplate Readers |
|
|
Accessories |
|
|
Incubator/Shaker
Microplate reader accessories used to heat and/or shake a sample at a constant rate during analysis.
Target Products:
|
|
|
General Laboratory Equipment |
|
|
Labware |
|
|
Thermometers
General laboratory products that are used to measure the temperature of a sample or a system.
Target Products:
|
|
|
Sample Preparation/Processing |
|
|
Centrifuges |
|
|
Systems |
|
|
Blood Bank
Centrifuges that are used to separate the different components of whole blood.
Target Products:
|
|
- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.
- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.
- Sector Participation. Denotes that the company develops products in this line of business.
Relationship Details
Key Competitors
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
Edwards Lifesciences Corp
|
|
n/a | 2,726.147 | 23.46 | 23.00 | 2.69 | 2.59 | 10.60 | |
Datascope Corporation
|
|
n/a | 501.115 | 29.49 | 18.50 | 1.36 | 1.21 | 1.95 | |
ABIOMED, Inc.
|
|
n/a | 390.774 | n/a | -20.16 | 8.10 | 7.92 | 10.08 | |
Merit Medical Systems, Inc.
|
|
n/a | 378.791 | 29.26 | 30.48 | 2.14 | 2.05 | 2.93 | |
AngioDynamics, Inc.
|
|
n/a | 280.451 | 40.84 | 26.65 | 3.57 | 2.77 | 2.34 | |
DURECT Corporation
|
|
n/a | 256.598 | n/a | -9.33 | 9.98 | 10.57 | 5.75 | |
Delcath Systems, Inc.
|
|
n/a | 92.484 | n/a | n/a | n/a | n/a | 7.04 | |
| Target | |||||||||
Johnson & Johnson
|
|
n/a | 189,307.421 | 17.32 | 17.52 | 3.69 | 3.57 | 6.89 | |
Biotest AG
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
DiaMed AG
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Olympus Optical Co., LTD.
|
|
n/a | n/a | n/a | 27.66 | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Dependent Suppliers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
QAD Inc.
|
|
n/a | 249.093 | 12.68 | 24.63 | 1.12 | 1.04 | 4.59 | |
| Target | |||||||||
Millipore Corporation
|
|
n/a | 3,441.281 | 39.30 | 22.60 | 3.32 | 2.85 | 4.50 | |
STRATEC Biomedical Systems AG
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Canadian Blood Services
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Lionheart Technologies, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Customers
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Target | |||||||||
Duke University Medical Center
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Kiwi Ingenuity Limited
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Blood Systems Laboratories
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Key Partners
| Name | Dir | Percent | Market Cap. | P/E Ratio (TTM) | Fwd P/E | P/R Ratio (TTM) | Fwd P/Rev | Price To Tang. Book Value | |
|---|---|---|---|---|---|---|---|---|---|
| Buyer | |||||||||
King Pharmaceuticals
|
|
n/a | 3,969.779 | 21.02 | 10.07 | 2.06 | 2.10 | 3.68 | |
The Cleveland Clinic Foundation
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
| Target | |||||||||
Allergan, Inc.
|
|
n/a | 17,254.709 | n/a | 31.39 | 6.56 | 5.76 | -756.79 | |
Millipore Corporation
|
|
n/a | 3,441.281 | 39.30 | 22.60 | 3.32 | 2.85 | 4.50 | |
STRATEC Biomedical Systems AG
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Kiwi Ingenuity Limited
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Canadian Blood Services
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
Lionheart Technologies, Inc.
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
University of Vermont
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | |
- Defined by the Company
- Defined by Others
Financials
| Buyer | Target | Combined Entity | |
|---|---|---|---|
| Income Statement | |||
| Operating Items | |||
| Revenue | 466.7 | 183.5 | 650.2 |
Other Revenue
|
0.0 | 0.0 | 0.0 |
| Total Revenue | 466.7 | 183.5 | 650.2 |
Cost of Revenue
|
248.5 | 62.0 | 310.4 |
SG&A Expense
|
131.2 | 50.8 | 182.0 |
Depreciation & Amortization
|
0.0 | 0.3 | 0.3 |
Research & Development
|
28.7 | 4.6 | 33.4 |
Interest Expense
|
0.0 | 0.0 | 0.0 |
Other Operating Expense
|
0.0 | 0.0 | 0.0 |
Unusual Expense (Income)
|
-0.0 | 2.7 | 2.7 |
| Total Expenses | 408.4 | 120.5 | 528.8 |
Operating Income
|
58.3 | 63.0 | 121.4 |
| Non Operating Items | |||
Interest Expense (Inc.), Net Non-Oprtng
|
2.7 | 0.5 | 3.2 |
Other, Net
|
0.0 | -0.3 | -0.3 |
| Income Before Taxes | 61.1 | 63.2 | 124.2 |
| Income Taxes | 17.7 | 23.3 | 41.0 |
| Income After Taxes | 43.4 | 39.8 | 83.2 |
Net Income - Excl. Xord. Items
|
43.4 | 39.8 | 83.2 |
Net Income - Incl. Xord. Items
|
43.4 | 39.8 | 83.2 |
Income Avail. to Common
|
43.4 | 39.8 | 83.2 |
| Share Items | |||
Basic Avg. Shares Outstanding
|
44.8 | 67.0 | 111.8 |
Basic EPS - Excl. Xord. Items
|
0.97 | 0.59 | 0.74 |
Basic EPS - Incl. Xord. Items
|
0.97 | 0.59 | 0.74 |
| Full Dilution Adjustment | 0.0 | 0.0 | 0.0 |
| Fully Diluted Shares Outstanding | 45.3 | 70.9 | 116.2 |
F.D. EPS - Excl. Xord. Items
|
0.96 | 0.56 | 0.72 |
F.D. EPS - Incl. Xord. Items
|
0.96 | 0.56 | 0.72 |
| Dividends Per Common Share | 0.64 | 0.00 | 0.64 |
| Balance Sheet | |||
| Assets | |||
Cash and Equivalents
|
130.8 | 54.1 | 184.9 |
ST Investments
|
2.5 | 1.6 | 4.1 |
Accounts Receivable
|
91.8 | 37.2 | 129.0 |
Inventory
|
101.8 | 20.7 | 122.5 |
Prepayments and Advances
|
11.8 | 5.2 | 17.0 |
Other Current Assets
|
12.7 | 2.0 | 14.7 |
Current Assets
|
351.4 | 120.8 | 472.2 |
PPE
|
353.4 | 0.0 | 353.4 |
Accum D&A
|
-185.4 | 0.0 | -185.4 |
PPE, Net
|
168.0 | 25.7 | 193.7 |
| Goodwill & Intangibles | 91.2 | 38.9 | 130.1 |
| Other Assets | 0.0 | 0.0 | 0.0 |
Other LT Assets
|
33.2 | 6.3 | 39.5 |
| Total Assets | 643.9 | 191.7 | 835.6 |
| Liabilities | |||
| Accounts Payable | 19.9 | 7.3 | 27.2 |
| Payable/Accrued | 0.0 | 0.0 | 0.0 |
| Accrued Expenses | 32.1 | 9.5 | 41.6 |
ST Debt
|
52.2 | 0.0 | 52.2 |
Curr Port of LTD & Cap Lease Oblg
|
1.0 | 1.1 | 2.1 |
| Other (Current) Liabilities | 8.0 | 10.1 | 18.1 |
Current Liab.
|
113.2 | 27.9 | 141.2 |
LT Debt
|
0.0 | 0.0 | 0.0 |
Total LT Debt
|
0.0 | 0.0 | 0.0 |
| Deferred Taxes | 6.3 | 2.2 | 8.6 |
Other LT Liab.
|
18.3 | 17.7 | 36.0 |
Total Liabilities
|
137.9 | 47.8 | 185.7 |
| Shareholders Equity | |||
| Common Stock | 45.7 | 6.8 | 52.5 |
| Additional Paid in Capital | 34.1 | 14.8 | 48.8 |
| Retained Earnings | 475.6 | 119.7 | 595.3 |
| Treasure Stock | -53.3 | 0.0 | -53.3 |
| Other Equity | 4.1 | 2.6 | 6.7 |
Total Equity
|
506.1 | 143.9 | 649.9 |
Total Liab. & Equity
|
643.9 | 191.7 | 835.6 |
Shares Outstanding
|
44.8 | 67.9 | 112.8 |
| Cash Flow | |||
| Operating Cash Flow | |||
| CF Net Income | 43.4 | 39.8 | 83.2 |
| CF Depreciation | 16.5 | 6.9 | 23.4 |
| CF Amortization | 5.8 | 0.0 | 5.8 |
| CF Deferred Taxes | -7.2 | -2.4 | -9.6 |
| Other Non-Cash Items | 27.6 | 3.8 | 31.4 |
| Change in Working Capital | -15.6 | 14.5 | -1.0 |
| Total Cash From Operating Activities | 70.6 | 62.7 | 133.3 |
| Investing Cash Flow (not calculated) | |||
| Capital Expenditures | -37.7 | -10.8 | -48.5 |
| Other Investing Cash Flows | -12.4 | -3.8 | -16.1 |
| Total Cash From Investing Activities | -50.1 | -14.6 | -64.7 |
| Financing Cash Flow (not calculated) | |||
| Dividends Paid | -27.7 | -0.0 | -27.7 |
| Purchase Or Sale of Stock | 4.6 | -22.8 | -18.2 |
| Purchase and Retirement of Debt | 22.1 | -8.3 | 13.8 |
| Other Financing Cash Flow | 0.6 | 0.0 | 0.6 |
| Total Cash From Financing Activities | -0.4 | -31.0 | -31.5 |
| Exchange Rate Effects | 1.4 | -0.1 | 1.3 |
| Net Change in Cash | 21.4 | 17.0 | 38.4 |
| Cash Taxes Paid | 14.3 | 18.1 | 32.3 |
| Cash Interest Paid | 0.8 | 0.5 | 1.3 |
Edwards Lifesciences Corp